---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-22-002480"
form_type: "8-K"
ticker: "CYTK"
cik: "0001061983"
company_name: "CYTOKINETICS INC"
filed_at: "2022-04-08T23:59:59+00:00"
generated_at: "2026-06-26T08:24:39.973587+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Cytokinetics appoints Robert Harrington as director; Dr. Gage resigns, Henderson becomes Chairman

## Summary
- Robert A. Harrington, M.D. appointed to Board, term through 2024 annual meeting; also joins Science and Technology Committee.
- Dr. Harrington receives $45,000 annual retainer (pro-rated) and option for 35,000 shares vesting over 3 years.
- L. Patrick Gage, Ph.D. resigns as director; not due to any disagreement with the company.
- John T. Henderson, M.D. appointed as Chairman of the Board following Dr. Gage's resignation.

## SEC filing metadata
- accession: 0001171843-22-002480
- form_type: 8-K
- ticker: CYTK
- cik: 0001061983
- company_name: CYTOKINETICS INC
- filed_at: 2022-04-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1061983/000117184322002480/0001171843-22-002480-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1061983/000117184322002480/f8k_040822.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-22-002480
- JSON: https://secwatch.observer/filing/0001171843-22-002480.json
- Plain text: https://secwatch.observer/filing/0001171843-22-002480.txt

## Key facts
- Executive change
  L. Patrick Gage resigned as Director at CYTOKINETICS INC.
  - Action: resigned
  - Role: Director
  source text: Also on the Effective Date, L. Patrick Gage, Ph.D. resigned as a director of Cytokinetics.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1061983/000117184322002480/0001171843-22-002480-index.htm
- Executive change
  Robert A. Harrington was appointed as Director at CYTOKINETICS INC.
  - Action: appointed
  - Role: Director
  source text: On April 8, 2022, (the “Effective Date”), the Board of Directors (the “Board”) of Cytokinetics, Incorporated (the “Company”) appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert A. Harrington, M.D. to fill a vacant Board seat and to serve as a member of the Board with an initial term expiring at the Company’s 2024 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1061983/000117184322002480/0001171843-22-002480-index.htm
- Executive change
  John T. Henderson was appointed as Chairman of the Board at CYTOKINETICS INC.
  - Action: appointed
  - Role: Chairman of the Board
  source text: As a result of Dr. Gage’s resignation, John T. Henderson, M.D. was appointed as Chairman of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1061983/000117184322002480/0001171843-22-002480-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.